Hormone Receptor Testing Rarely Guided Endocrine Therapy for Breast DCIS in New Zealand
A 23-year New Zealand population study found that oestrogen receptor testing and endocrine therapy for DCIS remained rare nationally, driven ...
A 23-year New Zealand population study found that oestrogen receptor testing and endocrine therapy for DCIS remained rare nationally, driven ...
A groundbreaking retrospective study led by King’s College London researchers has revealed that the 313-SNP breast cancer polygenic risk score, ...
An innovative clinical trial spearheaded by researchers at Northwestern Medicine has revealed unexpected potential for a drug already approved to ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine